Verastem (NasdaqCM:VSTM) Update / briefing June 23, 2026 04:30 PM ET Speaker11 Afternoon. Welcome to Verastem Oncology's VS-7375 R&D update conference call. My name is Tawanda, and I will be your call operator today. Please note this event is being recorded. All participants will be in a listen- only mode. After today's presentation, there will be an opportunity to ask questions. I will now turn the call over to Julissa Viana, Senior Vice President of Corporate Communications, Investor Relations, and Patien ...